ReviewInternational journal of bipolar disorders2020

Potential pharmacogenomic targets in bipolar disorder: considerations for current testing and the development of decision support tools to individualize treatment selection.

Alfredo B Cuéllar-Barboza et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.